Shock · 2010 · 74 citations · 30 references
Life SciencesImmunologyPharmacologyInflammationInnate ImmunitySignal TransductionAnti-inflammatory PharmacologyCytokine BiologyInflammatory Cell ResponsesInflammatory Cell SignalingInflammatory SignalingSepsis PathophysiologyExtracellular Signal-regulated Kinase PathwayExtracellular Signal-regulated Kinase SignalingInflammatory Signal TransductionInnate Immune Signaling ModulationMacrophage Oxidative StressSignal TransactivationToll-like Receptor-mediated Cytokine InductionToll-like Receptor-mediated Innate Immune Response
Lipoteichoic acid (LTA), a gram-positive bacterial outer membrane component, can cause septic shock. Our previous studies showed that ketamine has anti-inflammatory and antioxidant effects on gram-negative LPS-induced macrophage activation. In this study, we further evaluated the effects of ketamine on the regulation of LTA-induced TNF-alpha and IL-6 gene expressions and oxidative stress production in macrophages and its possible mechanisms. Exposure of macrophages to a therapeutic concentration of ketamine (100 microM) inhibited LTA-induced TNF-alpha and IL-6 expressions at protein or mRNA levels. In parallel, ketamine at 100 microM reduced LTA-stimulated phosphorylation of extracellular signal-regulated kinase 1/2 (ERK1/2). Sequentially, ketamine reduced the LTA-triggered translocation of nuclear factor-kappaB (NFkappaB) from the cytoplasm to nuclei and its transactivation activity. Pretreatment with PD98059, an inhibitor of ERK, decreased LTA-enhanced NFkappaB activation and TNF-alpha and IL-6 mRNA syntheses. Cotreatment with ketamine and PD98059 synergistically suppressed the LTA-induced translocation and transactivation of NFkappaB and biosyntheses of TNF-alpha and IL-6 mRNA. Application of Toll-like receptor 2 (TLR2) small interfering RNA (si)RNA into macrophages decreased the levels of this receptor, and simultaneously ameliorated LTA-augmented NFkappaB transactivation and consequent production of TNF-alpha and IL-6 mRNA. Cotreatment with ketamine and TLR2 siRNA synergistically lowered TNF-alpha and IL-6 mRNA syntheses in LTA-activated macrophages. Ketamine and TLR2 siRNA could reduce the LTA-induced increases in production of nitrite and intracellular reactive oxygen species in macrophages, and their combination had better effects than a single exposure. Thus, this study shows that one possible mechanism involved in ketamine-induced inhibition of LTA-induced TNF-alpha and IL-6 gene expressions and oxidative stress production is through downregulating TLR2-mediated phosphorylation of ERK1/2 and the subsequent translocation and transactivation of NFkappaB.
30
Patrick A. Baeuerle, David Baltimore · Cell · 1996 · 3K citations · Full text
Ketamine—Its Pharmacology and Therapeutic Uses
Paul F. White, Walter L. Way, Anthony J. Trevor · Anesthesiology · 1982 · 1.5K citations · Full text
Marina A. Dobrovolskaia, Andrei E. Medvedev, Karen E. Thomas et al. · The Journal of Immunology · 2003 · 301 citations · Full text